Newsroom All the latest news from the Pierre Fabre Group Page inner navigation PRESS RELEASES NEWS PUBLICATIONS Press releases Filter Year Year202520242023202220212020 Month MonthJanuaryFebruaryMarchAprilMayJuneJulyAugustSeptemberOctoberNovemberDecember Écrit le Min Max Appliquer Press release Pierre Fabre Laboratories presents the first global study on the “epidemiology of acne” 19 March 2024 Press release Kinnate Biopharma Inc. Sells Its Investigational Pan-RAF Inhibitor, Exarafenib, to Pierre Fabre Laboratories 5 March 2024 Press release Hervé Hoppenot, Incyte CEO, is appointed on the Board of Pierre Fabre Laboratories 10 January 2024 Load more News Filter Year Year202520242023202220212020 Month MonthJanuaryFebruaryMarchAprilMayJuneJulyAugustSeptemberOctoberNovemberDecember Tags (field_news_tags) - All - #CRCawarenessDuoDayE-SANTÉHappy New YearLittle Big DreamsInternational Men's Day#OurBreastJourneyCOLLECTION PIERRE FABREConsortiumSustainable developmentDIGITALEADVESMOThe Gustave Roussy PrizeLettre OuverteLymphomaMedicalInnovationMedicalScienceLiaisonMelanomaMSLPink OctoberOncologyANNUAL REPORTStudyEventsPierre Fabre FoundationInnovationNominationsPartnershipsAwardsStrategyTalents Écrit le Min Max Appliquer Awards PIERRE FABRE IS ONCE AGAIN ONE OF THE WORLD’S BEST EMPLOYERS 25 October 2022 Pierre Fabre Foundation UKRAINE – THE PIERRE FABRE FOUNDATION AND THE GROUP ARE TAKING ACTION TO SUPPORT REFUGEES 10 March 2022 Awards Pierre Fabre granted the BFM Awards 2021 for International Conquest 30 November 2021 Awards PIERRE FABRE AMONGST THE WORLD'S BEST EMPLOYERS IN 2021 10 November 2021 Load more Publications 20 March 2019 Pierre Fabre in brief leaflet Follow our live news Social media type (field_social_media_type) FacebookInstagramTwitterLinkedin Appliquer No post to display
Press release Pierre Fabre Laboratories presents the first global study on the “epidemiology of acne” 19 March 2024
Press release Kinnate Biopharma Inc. Sells Its Investigational Pan-RAF Inhibitor, Exarafenib, to Pierre Fabre Laboratories 5 March 2024
Press release Hervé Hoppenot, Incyte CEO, is appointed on the Board of Pierre Fabre Laboratories 10 January 2024
Pierre Fabre Foundation UKRAINE – THE PIERRE FABRE FOUNDATION AND THE GROUP ARE TAKING ACTION TO SUPPORT REFUGEES 10 March 2022